New perspectives on molecular targeted therapy in ovarian clear cell carcinoma

Ovarian clear cell carcinomas (OCCCs) account for about 5–13% of all epithelial ovarian carcinomas in Western populations. It is characterised by resistance to conventional platinum-based chemotherapy, and new therapeutic strategies are urgently required. This article will focus on how recent discov...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, D S P, Miller, R E, Kaye, S B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668466/
https://www.ncbi.nlm.nih.gov/pubmed/23558892
http://dx.doi.org/10.1038/bjc.2013.126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668466/
https://www.ncbi.nlm.nih.gov/pubmed/23558892
http://dx.doi.org/10.1038/bjc.2013.126

Ejemplares similares